Corpus Intelligence IC Memo — KPC PROMISE HOSPITAL OF WICHITA FALL 2026-04-26 12:45 UTC
IC Memo — KPC PROMISE HOSPITAL OF WICHITA FALL
Investment Committee Memorandum | TX | 31 beds | Grade D | EBITDA uplift $893K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KPC PROMISE HOSPITAL OF WICHITA FALL

CCN 452068 | WICHITA, TX | 31 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

KPC PROMISE HOSPITAL OF WICHITA FALL is a 31-bed rural/critical access in WICHITA, TX with $12.1M in net patient revenue and a 25.0% operating margin. The hospital serves a payer mix of 72.6% Medicare, 0.4% Medicaid, and 27.0% commercial.

Thesis: Turnaround. Our ML models identify $893K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 25.0% to 32.4% (+739bps).

Net Revenue HCRIS$12.1M
Current EBITDA COMPUTED$3.0M
Operating Margin COMPUTED25.0%
Occupancy HCRIS57.4%
Revenue / Bed COMPUTED$390K
Net-to-Gross HCRIS40.2%
Distress Probability ML49.5%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
272
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 25.0% places it above the state median. Among 272 size-comparable peers (16-62 beds), the median margin is -3.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (16-62), prioritizing same-state peers. 272 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KPC PROMISE HOSPITAL OF WICHIT (Target)TX31$12.1M25.0%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%
TEXAS SPINE AND JOINT HOSPITALTX20$147.3M30.3%
NORTH CENTRAL SURGICAL HOSPITATX24$143.6M32.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $893K (739bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$254K+210bp18mo
Cost to Collect4.5%2.5%$242K+200bp12mo
Denial Rate Reduction12.0%6.5%$241K+199bp12mo
A/R Days Reduction5200.0%3800.0%$147K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+8bp6mo

5. EBITDA Bridge

Net Collection Rate
$254K
Cost to Collect
$242K
Denial Rate Reduction
$241K
A/R Days Reduction
$147K
Clean Claim Rate
$10K
Total EBITDA Uplift$893K
Current EBITDA$3.0M
+ RCM Uplift+$893K
Pro Forma EBITDA$3.9M
Current Margin25.0%
Pro Forma Margin32.4%
WC Released (1x)$463K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$4.6M$28.8M6.21x44.1%
Base (11x exit)10.0x11.0x$4.6M$33.2M7.16x48.2%
Bull Case9.0x11.0x$4.2M$37.7M9.02x55.2%
Bull (12x exit)9.0x12.0x$4.2M$42.3M10.13x58.9%
Bear Case11.0x10.0x$5.1M$22.9M4.48x34.9%
Bear (11x exit)11.0x11.0x$5.1M$26.8M5.25x39.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 72.6% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 272 hospitals with 16-62 beds
  • Same-state prioritization (n=273)
  • Comp margins: P25=-29.3% / P50=-3.9% / P75=10.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.